Brookline Capital Management Upgrades BioVie (NASDAQ:BIVI) to Strong-Buy
Brookline Capital Management upgraded shares of BioVie (NASDAQ:BIVI – Free Report) to a strong-buy rating in a research report report published on Tuesday morning,Zacks.com reports. BioVie Stock Up 8.5 % Shares of BIVI opened at $1.15 on Tuesday. BioVie has a 52 week low of $0.99 and a 52 week high of $7.50. The company […]
Brookline Capital Management upgraded shares of BioVie (NASDAQ:BIVI – Free Report) to a strong-buy rating in a research report report published on Tuesday morning,Zacks.com reports. BioVie Stock Up 8.5 % Shares of BIVI opened at $1.15 on Tuesday. BioVie has a 52 week low of $0.99 and a 52 week high of $7.50. The company […]
